APC and neoplasm: However, it is noteworthy that, although APC→KRAS→TP53 is a widely perceived sequential pathway of the key driver mutation events commonly occurring in CRC development1, 10, 24, our data provide further clues in the development of CRC involving multiple pathways, as 156 tumours lack an APC mutation.